These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15701297)

  • 21. Safety and efficacy of pegylated interferon and ribavirin in adolescents with human immunodeficiency virus and hepatitis C virus acquired perinatally.
    Rosso R; Di Biagio A; Mikulska M; Nicco E; Bernardini C; Viscoli C
    J Med Virol; 2010 Jul; 82(7):1110-4. PubMed ID: 20513072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chronic hepatitis C in children: natural history and prognosis].
    Bortolotti F
    Recenti Prog Med; 2009 Feb; 100(2):97-102. PubMed ID: 19350803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of hepatitis B and C in children.
    El-Shabrawi M; Hassanin F
    Minerva Pediatr; 2014 Oct; 66(5):473-89. PubMed ID: 25253190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic hepatitis C virus infection in 2013--quo vadis?
    Prelipcean CC; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):7-10. PubMed ID: 24505885
    [No Abstract]   [Full Text] [Related]  

  • 25. Treating hepatitis C: are children the same as adults?
    Delgado-Borrego A
    Gastroenterology; 2011 Feb; 140(2):389-92. PubMed ID: 21172331
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study.
    Tan AC; Brouwer JT; Glue P; van Leusen R; Kauffmann RH; Schalm SW; de Vries RA; Vroom B
    Nephrol Dial Transplant; 2001 Jan; 16(1):193-5. PubMed ID: 11209032
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of PEG-interferon based treatment in patients with hepatitis C refractory to previous conventional interferon-based treatment.
    Shaikh S; Devrajani BR; Kalhoro M
    J Coll Physicians Surg Pak; 2012 Oct; 22(10):635-9. PubMed ID: 23058146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral hepatitis C.
    Poynard T; Yuen MF; Ratziu V; Lai CL
    Lancet; 2003 Dec; 362(9401):2095-100. PubMed ID: 14697814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hepatitis C.
    Heathcote J; Main J
    J Viral Hepat; 2005 May; 12(3):223-35. PubMed ID: 15850462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing and treating hepatitis C virus infection.
    Schiff ER
    Am J Manag Care; 2011 Mar; 17 Suppl 4():S108-15. PubMed ID: 21767067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peginterferon and ribavirin for chronic hepatitis C.
    Hoofnagle JH; Seeff LB
    N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of chronic hepatitis C in southern Taiwan.
    Chuang WL; Yu ML; Dai CY; Chang WY
    Intervirology; 2006; 49(1-2):99-106. PubMed ID: 16166797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectious disease. Despite setbacks, optimism on drugs for hepatitis C.
    Cohen J
    Science; 2012 Sep; 337(6101):1450-1. PubMed ID: 22997303
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of pegylated interferon α-2b and ribavirin in chronic hepatitis C virus (genotypes 1 and 4) infection.
    Wiśniewska-Ligier M; Pawłowska M; Pilarczyk M; Halota W; Woźniakowska-Gęsicka T
    J Pediatr Gastroenterol Nutr; 2013 Dec; 57(6):694-9. PubMed ID: 23942001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic hepatitis C: updated Swedish consensus.
    Wejstål R; Alaeus A; Fischler B; Reichard O; Uhnoo I; Weiland O;
    Scand J Infect Dis; 2003; 35(8):445-51. PubMed ID: 14514142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is (cost) effective in patients with chronic hepatitis C virus infection?
    Zeuzem S
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):473-6. PubMed ID: 11396523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developments in the treatment of chronic hepatitis C.
    Pockros PJ
    Expert Opin Investig Drugs; 2002 Apr; 11(4):515-28. PubMed ID: 11922860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of iron overload on the severity of liver histologic alterations and on the response to interferon and ribavirin therapy of patients with hepatitis C infection.
    Souza RM; Freitas LA; Lyra AC; Moraes CF; Braga EL; Lyra LG
    Braz J Med Biol Res; 2006 Jan; 39(1):79-83. PubMed ID: 16400467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and treatment of chronic hepatitis C. Practical recommendations and new developments].
    Niederau C
    Med Klin (Munich); 2001 Oct; 96(10):599-607. PubMed ID: 11715332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High sustained virological response rate to combination therapy in genotype 1 patients with histologically mild hepatitis C.
    Gheorghe L; Iacob S; Grigorescu M; Sporea I; Sirli R; Damian D; Gheorghe C; Iacob R
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):51-6. PubMed ID: 19337634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.